Request Demo
Last update 14 Mar 2026
SL-901
Last update 14 Mar 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SL 901 |
Target |
Action inhibitors |
Mechanism PI3K family inhibitors(Phosphatidylinositol 3-kinase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with SL-901NCT05382936
A Phase 1, Open-label, Dose-escalation Study of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors
100 Clinical Results associated with SL-901
Login to view more data
100 Translational Medicine associated with SL-901
Login to view more data
100 Patents (Medical) associated with SL-901
Login to view more data
100 Deals associated with SL-901
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Solid tumor | Phase 1 | Italy | 30 Jan 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | United Kingdom | 19 Mar 2021 | |
| Lung Cancer | Phase 1 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 20 | (Cohort 1: SL-901 20 mg) | uijcroydqz = zrxbdcvyxd vaxinspkpp (wxtuagujqd, yhwqqbnezt - vxrqjxkjlr) View more | - | 09 Jan 2025 | ||
(Cohort 2: SL-901 40 mg) | uijcroydqz = ulqptrwxxq vaxinspkpp (wxtuagujqd, ewzlhpkzpq - jhmayegfzg) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free